Jack N. Wells

Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor.

D. Scholl, J. N. Wells, J N Wells, 2000, Biochemical pharmacology.

Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2).

I. Biaggioni, L. Belardinelli, E. Garland, 2001, Biochemical pharmacology.

A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.

J. N. Wells, C. True, C. E. Piersen, 1994, Molecular pharmacology.